Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003*

Objective:To determine recent trends in rates of hospitalization, mortality, and hospital case fatality for severe sepsis in the United States. Design:Trend analysis for the period from 1993 to 2003. Setting:U.S. community hospitals from the Nationwide Inpatient Sample that is a 20% stratified sample of all U.S. community hospitals. Patients:Subjects of any age with sepsis including severe sepsis who were hospitalized in the United States during the study period. Interventions:None. Measurements and Main Results:Utilizing International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for septicemia and major organ dysfunction, we identified 8,403,766 patients with sepsis, including 2,857,476 patients with severe sepsis, who were hospitalized in the United States from 1993 to 2003. The percentage of severe sepsis cases among all sepsis cases increased continuously from 25.6% in 1993 to 43.8% in 2003 (p < .001). Age-adjusted rate of hospitalization for severe sepsis grew from 66.8 ± 0.16 to 132.0 ± 0.21 per 100,000 population (p < .001). Age-adjusted, population-based mortality rate within these years increased from 30.3 ± 0.11 to 49.7 ± 0.13 per 100,000 population (p < .001), whereas hospital case fatality rate fell from 45.8% ± 0.17% to 37.8% ± 0.10% (p < .001). During each study year, the rates of hospitalization, mortality, and case fatality increased with age. Hospitalization and mortality rates in males exceeded those in females, but case fatality rate was greater in females. From 1993 to 2003, age-adjusted rates for severe sepsis hospitalization and mortality increased annually by 8.2% (p < .001) and 5.6% (p < .001), respectively, whereas case fatality rate decreased by 1.4% (p < .001). Conclusions:The rate of severe sepsis hospitalization almost doubled during the 11-yr period studied and is considerably greater than has been previously predicted. Mortality from severe sepsis also increased significantly. However, case fatality rates decreased during the same study period.

[1]  I. Chaudry,et al.  Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. , 1997, Critical care medicine.

[2]  W. Baine,et al.  The epidemiology of hospitalization of elderly Americans for septicemia or bacteremia in 1991-1998. Application of Medicare claims data. , 2001, Annals of epidemiology.

[3]  Epidemiology of sepsis syndrome in 8 academic medical centers. , 1997 .

[4]  M. McBean,et al.  Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997. , 2001, The Journal of infectious diseases.

[5]  C. Sprung,et al.  Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.

[6]  J. Sunderram,et al.  Facing the challenge: Decreasing case fatality rates in severe sepsis despite increasing hospitalizations* , 2005, Critical care medicine.

[7]  Gary Garber,et al.  The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000) , 2001 .

[8]  J. Straková,et al.  Epidemiology of Severe Sepsis in Intensive Care Units in the Slovak Republic , 2005, Infection.

[9]  A. Kübler,et al.  Severe sepsis in Poland--results of internet surveillance of 1043 cases. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[10]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[11]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.

[12]  Mark Woodward,et al.  Epidemiology: Study Design and Data Analysis , 1999 .

[13]  Saxon Ridley.  Outcomes in critical care , 2002 .

[14]  Ruy Guilherme Rodrigues Cal,et al.  Brazilian Sepsis Epidemiological Study (BASES study) , 2004, Critical care.

[15]  G. Oster,et al.  Is sepsis accurately coded on hospital bills? , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[16]  S. Marsch,et al.  Burden of illness imposed by severe sepsis in Switzerland. , 2004, Swiss medical weekly.

[17]  H. Krumholz,et al.  Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. , 2005, The New England journal of medicine.

[18]  D. Pittet,et al.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.

[19]  D. Pittet,et al.  Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients , 1995, Intensive Care Medicine.

[20]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[21]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[22]  G. Rothe,et al.  Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: Gender-specific genetic predisposition to sepsis , 2001, Critical care medicine.

[23]  S. Geroulanos,et al.  Historical perspective of the word “sepsis” , 2006, Intensive Care Medicine.

[24]  B. van Hout,et al.  Prevalence and incidence of severe sepsis in Dutch intensive care units , 2004, Critical care.

[25]  François Gouin,et al.  Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units , 1995 .

[26]  F Doyon,et al.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.

[27]  V. Sundararajan,et al.  Epidemiology of sepsis in Victoria, Australia , 2005, Critical care medicine.

[28]  Djillali Annane,et al.  Reducing mortality in sepsis: new directions , 2002, Critical care.

[29]  Duncan Young,et al.  Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland , 2003, Critical care medicine.

[30]  P. Zabel,et al.  Gender differences in human sepsis. , 1998, Archives of surgery.

[31]  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.

[32]  J Z Ayanian,et al.  Differences in the use of procedures between women and men hospitalized for coronary heart disease. , 1991, The New England journal of medicine.

[33]  C. Brun-Buisson,et al.  EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units , 2004, Intensive Care Medicine.

[34]  J. Sutton,et al.  THE VALUE OF HOSPITAL DISCHARGE DATABASES , 2005 .

[35]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[36]  M. Wichmann,et al.  Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome , 2000, Intensive Care Medicine.

[37]  D. Bates,et al.  Epidemiology of sepsis syndrome in 8 academic medical centers. , 1997, JAMA.

[38]  P. Metnitz,et al.  Gender-related differences in intensive care: A multiple-center cohort study of therapeutic interventions and outcome in critically ill patients* , 2003, Critical care medicine.

[39]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[40]  Primary sepsis in a university hospital in northern Sweden: A retrospective study , 2004, Acta anaesthesiologica Scandinavica.

[41]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[42]  S. Hugonnet,et al.  Bacteremic sepsis in intensive care: Temporal trends in incidence, organ dysfunction, and prognosis , 2003, Critical care medicine.

[43]  Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987. , 1990, MMWR. Morbidity and mortality weekly report.

[44]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[45]  R. Bellomo,et al.  Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units , 2004, Intensive Care Medicine.

[46]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[47]  Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. , 2005 .

[48]  Marc Moss,et al.  The role of infection and comorbidity: Factors that influence disparities in sepsis , 2006, Critical care medicine.